# A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations

> **NCT00942604** · PHASE3 · COMPLETED · sponsor: **Peplin** · enrollment: 203 (actual)

## Conditions studied

- Actinic Keratoses

## Interventions

- **DRUG:** PEP005 (ingenol mebutate) Gel
- **DRUG:** Vehicle gel

## Key facts

- **NCT ID:** NCT00942604
- **Lead sponsor:** Peplin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2015-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00942604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00942604, "A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00942604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*